Postmarket Surveillance of Blood Glucose Monitor Systems Is Needed for Safety of Subjects and Accurate Determination of Effectiveness in Clinical Trials of Diabetes Drugs and Devices

DOI: 10.1177/1932296819843398

Keywords: accuracy,blood glucose monitor,clinical trial,FDA,surveillance

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text